Welcome to the Working Group on New TB Drugs Blog
Posted in TB Prevention and Control Strategies, Video, Voices from the Fight to Stop Tuberculosis
Interview with Dr. Lee Reichman – Part Three
This is part three of our interview with Lee B. Reichman, MD, MPH, Founding Executive Director of the New Jersey Medical School Global Tuberculosis Institute, and Professor of Medicine, Preventive Medicine and Community Health at the New Jersey Medical School, in Newark, New Jersey.
Posted in TB Prevention and Control Strategies, Video, Voices from the Fight to Stop Tuberculosis
Interview with Dr. Lee Reichman – Part Two
This is part two of our interview with Lee B. Reichman, MD, MPH, Founding Executive Director of the New Jersey Medical School Global Tuberculosis Institute, and Professor of Medicine, Preventive Medicine and Community Health at the New Jersey Medical School, in Newark, New Jersey.
Viewpoint: We Need New TB Drugs – Part Two
Last week, Dr. Kaiser shared his thoughts and perspectives as a medical doctor on the current state of TB drug regimens. This week he shares specific ideas on how TB drug R&D could be improved.
Viewpoint: We Need New TB Drugs – Part One
Antibiotics are, to the typical patient, always the quick fix. Despite our best attempts to convince them that their viral bronchitis will get better without that course of amoxicillin, anyone who has worked a primary care clinic knows the pressure to throw antibiotics at the problem, even when we ourselves know it’s not the answer, because our patients perceive it as the fast track to health. A couple weeks, they reason, and the infection is over. Normalcy ought to resume. Then you tell them they have tuberculosis, and “normalcy” is at least six months away, if everything goes according to plan. And tuberculosis is a wily enough contender to make sure everything won’t.
TB Treatment Stories
This is the first in our series “TB Treatment Stories,” where we meet people who have had first-hand experience taking standard tuberculosis drugs, which were developed and approved more than 40 years ago. As the Working Group for New TB Drugs works with today’s researchers to develop better therapies, a look at the day to day realities of extended treatment regimen and side effects of the old drugs provides perspective on why new treatments are so desperately needed.
Posted in TB Prevention and Control Strategies, Video, Voices from the Fight to Stop Tuberculosis
Interview with Dr. Lee Reichman – Part One
This is part one of our interview with Lee B. Reichman, MD, MPH, Founding Executive Director of the New Jersey Medical School Global Tuberculosis Institute, and Professor of Medicine, Preventive Medicine and Community Health at the New Jersey Medical School, in Newark, New Jersey.
The Outcasts of Tuberculosis
It may be curable but Tuberculosis (TB) remains a stigma in our country especially for women. Over a lakh Indian women are thrown out of their homes each year because they have TB. NDTV brings you the story of a woman who was deserted by her husband one year after marriage because she was diagnosed with TB. The 21-year-old woman’s only fault was that she was infected with tuberculosis.
Stop TB Partnership Craig David Video Series #2
The Stop TB Partnership has produced a series of videos featuring Goodwill Ambassador Craig David. This is #2 in a series.
An Interview with Martino Laurenzi, M.D., MPH
Dr. Martino Laurenzi, an expert in clinical development and community health, is a Clinical Research Scientist at the TB Alliance, where his responsibilities include the oversight of clinical trials. Dr. Laurenzi has long been involved in public health research; the Gubbio Study, which he started in 1982 in the Italian town for which it is named, is one of the longest standing population-based epidemiological studies for the screening of cardiovascular risk factors.
An Interview with Michael D. Iseman, M.D.
Dr. Michael D. Iseman is a Professor of Medicine in the Divisions of Pulmonary Medicine and Infectious Diseases at the University of Colorado School of Medicine. This video was recorded on November 13, 2009 at Johns Hopkins University.
